Apeloa Pharmaceutical Co. Ltd. Class A 000739

SZSE · China · Health Technology

CNY 27.74+1.18 (+4.44%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Apeloa Pharmaceutical Co. Ltd. Class A 000739

SZSE · China · Health Technology

CNY 27.74+1.18 (+4.44%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Company news

Yahoo FinanceSep 17, 2026

Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award

Global GIL Recognition Spotlights Apeloa’s End-to-End "API + Drug Product" Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated MarketsSHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven pharmaceutical manufacturer, announced that it has been awarded the “2026 Global CDMO Company of the Year Award” by growth advisory fi

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.